nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—Pargyline—MAOA—bipolar disorder	0.0453	0.0843	CrCbGaD
Tripelennamine—Alverine—HTR1A—bipolar disorder	0.0433	0.0805	CrCbGaD
Tripelennamine—Captodiame—DRD3—bipolar disorder	0.042	0.0781	CrCbGaD
Tripelennamine—Orphenadrine—GRIN1—bipolar disorder	0.0389	0.0724	CrCbGaD
Tripelennamine—Amitriptyline—NTRK2—bipolar disorder	0.0389	0.0723	CrCbGaD
Tripelennamine—Captodiame—HTR2C—bipolar disorder	0.0353	0.0656	CrCbGaD
Tripelennamine—Bepridil—CACNA1C—bipolar disorder	0.0309	0.0574	CrCbGaD
Tripelennamine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.0248	0.0537	CbGpPWpGaD
Tripelennamine—Amitriptyline—NTRK1—bipolar disorder	0.024	0.0447	CrCbGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0209	0.0452	CbGpPWpGaD
Tripelennamine—Chlorphenamine—SLC6A3—bipolar disorder	0.0176	0.0327	CrCbGaD
Tripelennamine—Benzphetamine—SLC6A3—bipolar disorder	0.0149	0.0277	CrCbGaD
Tripelennamine—Cyclobenzaprine—HTR2A—bipolar disorder	0.0145	0.0269	CrCbGaD
Tripelennamine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0145	0.0313	CbGpPWpGaD
Tripelennamine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.014	0.0303	CbGpPWpGaD
Tripelennamine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.014	0.0303	CbGpPWpGaD
Tripelennamine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0135	0.0293	CbGpPWpGaD
Tripelennamine—Chlorphenamine—SLC6A4—bipolar disorder	0.0132	0.0245	CrCbGaD
Tripelennamine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0131	0.0285	CbGpPWpGaD
Tripelennamine—Promazine—DRD4—bipolar disorder	0.0129	0.0239	CrCbGaD
Tripelennamine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0122	0.0265	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0122	0.0263	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.012	0.0261	CbGpPWpGaD
Tripelennamine—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.0118	0.0256	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0118	0.0254	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0118	0.0254	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0114	0.0246	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.011	0.0239	CbGpPWpGaD
Tripelennamine—Promazine—DRD1—bipolar disorder	0.0109	0.0202	CrCbGaD
Tripelennamine—Doxepin—HTR2C—bipolar disorder	0.0105	0.0195	CrCbGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0103	0.0223	CbGpPWpGaD
Tripelennamine—Doxepin—HTR1A—bipolar disorder	0.0102	0.0189	CrCbGaD
Tripelennamine—Amitriptyline—DRD3—bipolar disorder	0.00965	0.0179	CrCbGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.00943	0.0204	CbGpPWpGaD
Tripelennamine—Promazine—HTR2C—bipolar disorder	0.00931	0.0173	CrCbGaD
Tripelennamine—Imipramine—SLC6A3—bipolar disorder	0.00903	0.0168	CrCbGaD
Tripelennamine—Doxepin—SLC6A4—bipolar disorder	0.00868	0.0161	CrCbGaD
Tripelennamine—Doxepin—DRD2—bipolar disorder	0.00863	0.016	CrCbGaD
Tripelennamine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00858	0.0186	CbGpPWpGaD
Tripelennamine—Imipramine—HTR2C—bipolar disorder	0.00815	0.0151	CrCbGaD
Tripelennamine—Amitriptyline—HTR2C—bipolar disorder	0.0081	0.0151	CrCbGaD
Tripelennamine—Imipramine—HTR1A—bipolar disorder	0.00791	0.0147	CrCbGaD
Tripelennamine—Amitriptyline—HTR1A—bipolar disorder	0.00786	0.0146	CrCbGaD
Tripelennamine—Promazine—DRD2—bipolar disorder	0.00767	0.0143	CrCbGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00721	0.0156	CbGpPWpGaD
Tripelennamine—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.00693	0.015	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00678	0.0147	CbGpPWpGaD
Tripelennamine—Imipramine—SLC6A4—bipolar disorder	0.00675	0.0125	CrCbGaD
Tripelennamine—Imipramine—DRD2—bipolar disorder	0.00672	0.0125	CrCbGaD
Tripelennamine—Amitriptyline—SLC6A4—bipolar disorder	0.00671	0.0125	CrCbGaD
Tripelennamine—Amitriptyline—DRD2—bipolar disorder	0.00668	0.0124	CrCbGaD
Tripelennamine—Doxepin—HTR2A—bipolar disorder	0.00667	0.0124	CrCbGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00606	0.0131	CbGpPWpGaD
Tripelennamine—Promazine—HTR2A—bipolar disorder	0.00593	0.011	CrCbGaD
Tripelennamine—Imipramine—HTR2A—bipolar disorder	0.00519	0.00964	CrCbGaD
Tripelennamine—Amitriptyline—HTR2A—bipolar disorder	0.00516	0.00958	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00479	0.0104	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.0047	0.0102	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00461	0.00999	CbGpPWpGaD
Tripelennamine—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00455	0.00985	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00437	0.00945	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.0042	0.00909	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.0041	0.00889	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.0039	0.00846	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00356	0.00771	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00349	0.00756	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00318	0.00689	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00314	0.0068	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00313	0.00677	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00312	0.00676	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00289	0.00626	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00289	0.00626	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00279	0.00605	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.0027	0.00584	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.0027	0.00584	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00261	0.00566	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00254	0.00549	CbGpPWpGaD
Tripelennamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00252	0.00546	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00239	0.00518	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00236	0.00512	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00236	0.0051	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00231	0.00501	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00231	0.00501	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00226	0.00489	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00224	0.00485	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.0022	0.00477	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.0022	0.00477	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00217	0.00471	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00214	0.00464	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00204	0.00443	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00202	0.00438	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00193	0.00418	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00191	0.00415	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00182	0.00395	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00179	0.00389	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00177	0.00382	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00176	0.00381	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00176	0.00381	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00175	0.0038	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00173	0.00375	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.0017	0.00369	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.00168	0.00364	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.00167	0.00361	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.00166	0.00359	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00166	0.00358	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00166	0.00358	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.0016	0.00347	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00157	0.00341	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00154	0.00334	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—IMPA2—bipolar disorder	0.00144	0.00311	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00142	0.00307	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00134	0.0029	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00128	0.00276	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00124	0.00269	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00124	0.00269	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00124	0.00269	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00122	0.00263	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.00116	0.00251	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00113	0.00245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00113	0.00245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00113	0.00245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00113	0.00245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00113	0.00244	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—POMC—bipolar disorder	0.00109	0.00235	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00108	0.00234	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00104	0.00224	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00103	0.00223	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00101	0.0022	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000995	0.00215	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.000995	0.00215	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000971	0.0021	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.000963	0.00209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.000947	0.00205	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.000935	0.00203	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.000935	0.00203	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.000929	0.00201	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.000921	0.00199	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.000903	0.00196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.000903	0.00196	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.00088	0.00191	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.000875	0.00189	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.000871	0.00189	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.000862	0.00187	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.000849	0.00184	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000826	0.00179	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.0008	0.00173	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.000799	0.00173	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.000791	0.00171	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000718	0.00156	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.000718	0.00155	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCAN—bipolar disorder	0.000687	0.00149	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000685	0.00148	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000673	0.00146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000668	0.00145	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000668	0.00145	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000668	0.00145	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.00061	0.00132	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000554	0.0012	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000553	0.0012	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000544	0.00118	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000534	0.00116	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000534	0.00116	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000519	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000517	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000515	0.00111	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000502	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000487	0.00106	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.000487	0.00105	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000474	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000474	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000474	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000472	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000471	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000467	0.00101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000467	0.00101	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000443	0.000958	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	0.000434	0.000939	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000423	0.000916	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	0.000423	0.000915	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000411	0.000891	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SNAP25—bipolar disorder	0.000379	0.000821	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.000363	0.000786	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADCY2—bipolar disorder	0.000336	0.000727	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.000327	0.000709	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COMT—bipolar disorder	0.000287	0.000622	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MAOA—bipolar disorder	0.000285	0.000618	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000264	0.000571	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.000261	0.000566	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—INS—bipolar disorder	0.00026	0.000563	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—bipolar disorder	0.000232	0.000503	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—POMC—bipolar disorder	0.000186	0.000402	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—INS—bipolar disorder	0.000185	0.0004	CbGpPWpGaD
